HOME >> BIOLOGY >> NEWS
Toward improved forms of a time-tested cholesterol-fighter

CHICAGO, March 27 New discoveries offer promise for developing drugs that improve on the therapeutic profile of niacin, the inexpensive, time-tested B-vitamin that boosts levels of HDL cholesterol the good cholesterol with the potential to protect people against heart attacks and stroke, scientists reported today.

Graeme Semple, Ph.D., Vice President of Discovery Chemistry at Arena Pharmaceuticals, San Diego, Calif., described new insights into developing drugs that raise HDL via the same mechanism as niacin in a report scheduled for presentation at the 233rd national meeting of the American Chemical Society, being held here this week.

In small doses, niacin is the familiar B-complex vitamin, which helps the body metabolize or breakdown carbohydrates, fats and protein into compounds that the body needs to maintain good health. In the high doses prescribed by a physician, niacin can increase HDL by as much as 35 percent and reduce levels of artery-clogging triglycerides by 50 percent.

Doctors have known since the 1970s that niacin can reduce the risk of heart attacks and strokes, but it has not been prescribed as widely as newer and more costly medications known as statins.

The use of niacin is limited by its side-effects, including a highly uncomfortable skin flushing, which contributes significantly to poor patient compliance, Semple explained. Since currently marketed cholesterol drugs have a more modest HDL-raising activity than niacin, better tolerated HDL-targeted therapies with improved efficacy could provide additional clinical benefits to patients and potentially reduce the risk of heart attack and stroke.

Semple described research toward that goal, including Arenas discovery of a niacin receptor termed GPR109a. It is among a family of so-called G protein-coupled receptors (GPCRs) that have long been considered among scientists as good targets for the development of new drugs.

Molecules terme
'"/>


27-Mar-2007


Page: 1 2

Related biology news :

1. Toward more effective paleolgenetic analysis
2. Dengue and other hemorrhagic fevers: Towards a first potential treatment
3. Towards predicting late-stage radiation toxicity
4. Toward a less expensive, more convenient treatment of Gauchers disease
5. Towards the mechanism of cell respiration
6. Towards a unified model of transcription termination
7. Towards a cheap and easy way to monitor HIV/AIDS
8. Towards targeted lung cancer treatment
9. Toward a better understanding of taste and smell impairments
10. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
11. Gene expression pattern could lead to improved treatment of pediatric septic shock

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/12/2019)... ... March 12, 2019 , ... FEITIAN Technologies US Inc. ... cards, announced today the launch of two new payment card types which can ... Payment cards. These advanced technologies will help all elements of the payment card ...
(Date:3/9/2019)... N.Y. (PRWEB) , ... March 07, 2019 , ... A ... $1,000 to The Leukemia & Lymphoma Society (LLS). This donation will help fund not ... to patients and their families. , “We are always on the lookout for ...
(Date:3/9/2019)... ... March 09, 2019 , ... Hello Bio announces the ... compounds for scientists studying GPCR and DREADD signalling. Hello Bio has been granted ... of Neurological Disorders and Stroke, both institutes of the National Institutes of Health, ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... March 19, 2019 , ... Cirrascale ... announced it has extended its managed services offering to include NVIDIA® DGX™ systems. ... are part of the NVIDIA DGX-Ready Data Center program to deliver a Zero ...
(Date:3/19/2019)... JOSE, Calif. (PRWEB) , ... March 19, 2019 ... ... of multi-GPU deep learning cloud solutions, today announced it has begun offering NVIDIA® ... service offerings. Customers can utilize DGX-1, designed to provide the highest performance for ...
(Date:3/14/2019)... , ... March 14, 2019 , ... ... Conference & Expo, themed “Navigating the Full Spectrum of Case Management,” continues as ... 10-14, 2019. This conference is the only case management industry conference serving the ...
(Date:3/12/2019)... ... March 11, 2019 , ... Centura ... Colorado, and among the first in the nation, to offer needle-free blood draws ... placement and overall degree to which staff showed compassion jumped up by an ...
Breaking Biology Technology:
Cached News: